Microglial dysfunction in brain aging and Alzheimer's disease - PubMed (original) (raw)
Review
Microglial dysfunction in brain aging and Alzheimer's disease
Kira Irving Mosher et al. Biochem Pharmacol. 2014.
Abstract
Microglia, the immune cells of the central nervous system, have long been a subject of study in the Alzheimer's disease (AD) field due to their dramatic responses to the pathophysiology of the disease. With several large-scale genetic studies in the past year implicating microglial molecules in AD, the potential significance of these cells has become more prominent than ever before. As a disease that is tightly linked to aging, it is perhaps not entirely surprising that microglia of the AD brain share some phenotypes with aging microglia. Yet the relative impacts of both conditions on microglia are less frequently considered in concert. Furthermore, microglial "activation" and "neuroinflammation" are commonly analyzed in studies of neurodegeneration but are somewhat ill-defined concepts that in fact encompass multiple cellular processes. In this review, we have enumerated six distinct functions of microglia and discuss the specific effects of both aging and AD. By calling attention to the commonalities of these two states, we hope to inspire new approaches for dissecting microglial mechanisms.
Keywords: Aging; Alzheimer's disease; Microglia; Neurodegeneration; Neuroinflammation.
Published by Elsevier Inc.
Figures
Figure 1
The hallmarks of microglial aging. The six major effector functions/phenotypes of microglia that are the focus of this review are highlighted at the outer ring of this schematic: proliferation, morphology, motility and migration, intercellular communication, proteostasis, and phagocytosis. Within the inner ring of the circle we describe the effects of aging on each of these functions.
Figure 2
Microglia molecules genetically implicated in Alzheimer’s disease. Recent studies have identified novel risk factors for AD such as TREM2, which together with previous work, strongly point to a role for microglia and immune mechanisms in the disease. NLRP3 inflammasome activation in microglia mediates a harmful inflammatory response that contributes to AD pathology. On the other hand, microglia express several receptors that bind Aβ (such as scavenger receptor A, RAGE, CD36, CR1, CR3, and toll-like receptors) as well as enzymes that degrade soluble Aβ (i.e., insulin-degrading enzyme, neprilysin, MMP), which may contribute to the clearance of amyloid thus offer protective functions. Likewise, beclin 1, which is decreased in the brains of AD patients, regulates the recycling of receptors such as CD36 and TREM2 and phagocytosis.
Figure 3
Understanding the intersection of microglial aging and Alzheimer’s disease. The hallmarks of microglial aging may be further exacerbated in AD as a result of disease-associated genetic variants and environmental influences. Potential connections between these phenotypes are shown in the figure. Such impairments in microglial functions may contribute to both aging and disease phenotypes and neuronal degeneration and dysfunction.
Similar articles
- The age-related microglial transformation in Alzheimer's disease pathogenesis.
Yuan C, Aierken A, Xie Z, Li N, Zhao J, Qing H. Yuan C, et al. Neurobiol Aging. 2020 Aug;92:82-91. doi: 10.1016/j.neurobiolaging.2020.03.024. Epub 2020 Apr 15. Neurobiol Aging. 2020. PMID: 32408056 Review. - Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ, Braak H, Xue QS, Bechmann I. Streit WJ, et al. Acta Neuropathol. 2009 Oct;118(4):475-85. doi: 10.1007/s00401-009-0556-6. Epub 2009 Jun 10. Acta Neuropathol. 2009. PMID: 19513731 Free PMC article. - Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE, Allison EK, El Khoury J. Hickman SE, et al. J Neurosci. 2008 Aug 13;28(33):8354-60. doi: 10.1523/JNEUROSCI.0616-08.2008. J Neurosci. 2008. PMID: 18701698 Free PMC article. - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, Duong DM, Pennington MW, Lah JJ, Seyfried NT, Levey AI. Rangaraju S, et al. Mol Neurodegener. 2018 May 21;13(1):24. doi: 10.1186/s13024-018-0254-8. Mol Neurodegener. 2018. PMID: 29784049 Free PMC article. - Microglia in Brain Development, Homeostasis, and Neurodegeneration.
Bohlen CJ, Friedman BA, Dejanovic B, Sheng M. Bohlen CJ, et al. Annu Rev Genet. 2019 Dec 3;53:263-288. doi: 10.1146/annurev-genet-112618-043515. Epub 2019 Sep 13. Annu Rev Genet. 2019. PMID: 31518519 Review.
Cited by
- The choreography of neuroinflammation in Huntington's disease.
Crotti A, Glass CK. Crotti A, et al. Trends Immunol. 2015 Jun;36(6):364-73. doi: 10.1016/j.it.2015.04.007. Epub 2015 May 20. Trends Immunol. 2015. PMID: 26001312 Free PMC article. Review. - Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.
Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Fulop T, et al. Neuropsychiatr Dis Treat. 2021 May 4;17:1311-1339. doi: 10.2147/NDT.S264910. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 33976546 Free PMC article. Review. - Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
Johnson CE, Duncan MJ, Murphy MP. Johnson CE, et al. J Alzheimers Dis. 2024;97(1):31-74. doi: 10.3233/JAD-230527. J Alzheimers Dis. 2024. PMID: 38007653 Free PMC article. Review. - TREX1 is required for microglial cholesterol homeostasis and oligodendrocyte terminal differentiation in human neural assembloids.
Goldberg G, Coelho L, Mo G, Adang LA, Patne M, Chen Z, Garcia-Bassets I, Mesci P, Muotri AR. Goldberg G, et al. Mol Psychiatry. 2024 Mar;29(3):566-579. doi: 10.1038/s41380-023-02348-w. Epub 2023 Dec 21. Mol Psychiatry. 2024. PMID: 38129659 Free PMC article.
References
- Stelzmann R, Norman Schnitzlein H, Reed Murtagh F. An English translation of Alzheimer’s 1907 paper, “Über eine eigenartige Erkankung der Hirnrinde”. Clinical anatomy. 1995;8(6):429–431. - PubMed
- Samorajski T. How the human brain responds to aging. J Am Geriatr Soc. 1976;24(1):4–11. - PubMed
- Hanisch U-K, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387–94. - PubMed
- Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8(6):752–758. - PubMed
Publication types
MeSH terms
Grants and funding
- AG03144/AG/NIA NIH HHS/United States
- R01 AG045034/AG/NIA NIH HHS/United States
- R01 AG030144/AG/NIA NIH HHS/United States
- 1 F31 AG040877-01A1/AG/NIA NIH HHS/United States
- AG045034/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous